Abstract
A prospective study was initiated to analyse the bacterial aetiology and clinical picture of mild community-acquired pneumonia in Slovenia using the previously described Pneumonia Severity Index. Radiographically confirmed cases of pneumonia in patients treated with oral antibiotics in seven study centres were included. An aetiological diagnosis was attempted using culture of blood and sputum, urinary antigen testing for Streptococcus pneumoniae and Legionella pneumophila, and antibody testing for Mycoplasma pneumoniae, Chlamydia pneumoniae, and Legionella pneumophila in paired serum samples. One hundred thirteen patients were evaluable for clinical presentation and 109 for aetiological diagnosis. At least one pathogen was detected in 62.4% patients. The most common causative agents were Mycoplasma pneumoniae in 24.8%, Chlamydia pneumoniae in 21.1%, and Streptococcus pneumoniae in 13.8% of patients. Dual infection was detected in 8.3% of patients. Most patients suffered from cough, fatigue, and fever. Patients with atypical aetiology of pneumonia differed from those with typical bacterial pneumonia or pneumonia of unknown aetiology in age, presence of dyspnea, and bronchial breathing on lung auscultation. Patients with pneumococcal, chlamydial, and mycoplasmal infections differed in age, risk class, presence of dyspnea, bronchial breathing, and proteinuria. There was an overlap of other clinical symptoms, underlying conditions, and laboratory and radiographic findings among the groups of patients classified by aetiology. Since patients with mild community-acquired pneumonia exhibit similar clinical characteristics and, moreover, since a substantial proportion of cases are attributable to atypical bacteria, broad-spectrum antibiotic treatment seems to be recommended.
Similar content being viewed by others
References
Marrie TJ (1998) Epidemiology of mild pneumonia. Semin Resp Infect 13:3−7
Woodhead MA, MacFarlane JT, McCracken JS, Rose DH, Finch RG (1987) Prospective study of the aetiology and outcome of pneumonia in the community. Lancet i:671−674
Jokinen C, Heiskanen L, Juvonen H, Kallinen S, Kleemola M, Koskela M, Leinonen M, Rönnberg PR, Saikku P, Sten M, Tarkianen A, Tukiainen H, Pjörälä K, Mäkela PH (2001) Microbial aetiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland. Clin Infect Dis 32:1141−1154
Fine MJ, Auble TE, Yealy DM, Hanusa BH, Weissfeld LA, Singer DE, Coley CM, Marrie TJ, Kapoor WN (1997) A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 336:243−250
Cunha BA (2000) The diagnostic significance of relative bradycardia in infectious diseases. Clin Microbiol Infect 6:633−634
Waris ME, Toikka P, Saarinen T, Nikkari S, Meurman O, Vainiopää R, Mertsola J, Ruuskanen O (1998) Diagnosis of Mycoplasma pneumoniae pneumonia in children. J Clin Microbiol 36:3155−3159
Anonymous (1997) Case definitions for infectious conditions under public health surveillance. MMWR 44:RR-10
Dowell SF, Peeling RW, Boman J, Carlone GM, Fields BS, Guarner J, Hammerschlag MR, Jackson LA, Kuo C, Maass M, Messmer TO, Talkington DF, Tondella ML, Zaki SR, and the C. pneumoniae Workshop Participants (2001) Standardizing Chlamydia pneumoniae assays: recommendations from the Centers for Disease Control and Prevention (CDC) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 33:492−503
Berntsson E, Lagergard T, Strannegard O, Trollfors B (1986) Aetiology of community-acquired pneumonia in outpatients. Eur J Clin Microbiol 5:446−447
Marrie TJ, Peeling RW, Fine MJ, Singer DE, Coley CM, Kapoor WN (1996) Ambulatory patients with community-acquired pneumonia: the frequency of atypical agents and clinical course. Am J Med 101:508−515
Blanquer J, Blanquer R, Borras R, Nauffal D, Morales P, Menendez R, Subias I, Herrero L, Redon J, Pascual J (1991) Aetiology of community-acquired pneumonia in Valencia, Spain: a multicentre prospective study. Thorax 46:508−511
Almirall J, Morato I, Riera F, Verdaguer A, Priu R, Coll P, Vidal J, Murgui L, Vals F, Catalan F, Balanzo X (1993) Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection: a prospective multicentre study. Eur J Respir 6:14−18
Bochud PY, Moser F, Erard P, Verdon F, Studer JP, Villard G, Coseendai A, Cotting M, Heim F, Tissot J, Strub Y, Pazeller M, Saghafi L, Wenger A, Germann D, Matter L, Bille J, Pfister L, Francioli P (2001) Community-acquired pneumonia. A prospective outpatient study. Medicine 80:75−87
Falguera M, Sacristan O, Nogues A, Ruiz-Gonzales A, Garcia M, Manonelles A, Rubio-Caballero M (2001) Nonsevere community-acquired pneumonia. Arch Intern Med 161:1866−1872
Roson B, Carratala J, Dorca J, Casanova A, Manresa F, Gudiol F (2001) Aetiology, reasons for hospitalization, risk classes, and outcomes of community-acquired pneumonia in patients hospitalized on the basis of conventional admission criteria. Clin Infect Dis 33:158−165
British Thoracic Society Standards of Care Committee (2001) BTS guidelines for the management of community-acquired pneumonia in adults. Thorax 56 [Suppl 4]:1−64
Lieberman D, Ben-Yaakov M, Lazarowich Z, Porath A, Schaeffler F, Lieberman D, Leinonen M, Saikku P, Horovitz O, Boldur I (1996) Chlamydia pneumoniae community-acquired pneumonia: a review of 62 hospitalized adult patients. Infection 24:109−113
Keše D, Čižman M, Marin J, Avšič-Zupanc T (2002) Chlamydia pneumoniae infections in patients with community-acquired pneumonia in Slovenia. Scand J Infect Dis 34:172−176
Sočan M, Marinič-Fišer N, Kraigher A, Kotnik A, Logar M (1999) Microbial aetiology of community-acquired pneumonia in hospitalized patients. Eur J Clin Microbiol Infect Dis 18:777−782
Uldum SA, Sondergard-Andersen J, Skov Jensen J, Lind K (1990) Evaluation of a commercial enzyme immunoassay for detection of Mycoplasma pneumoniae specific immunoglobulin G antibodies. Eur J Clin Infect Dis 9:211−213
Hirschber L, Krook A, Petterson CA, Vilkerfors T (1988) Enzyme-linked immunosorbent assay for detection of Mycoplasma pneumoniae specific immunoglobulin M. Eur J Clin Microbiol Infect Dis 7:420−423
Uldum SA, Jensen JS, Sondergard-Andersen J, Lind K (1992) Enzyme immunoassay for detection of immunoglobulin M (IgM) and IgG antibodies to Mycoplasma pneumoniae. J Clin Microbiol 30:1198−1204
Rastawicki W, Jagielsi M (1996) Enzyme-linked immunosorbent assay, complement fixation test and immunoelectroprecipitation test in the diagnosis of Mycoplasma pneumoniae infections − comparative analysis. Zentralbl Bakteriol 283:477−484
Thacker WL, Talkington DF (2000) Analysis of complement fixation and commercial enzyme immunoassays for detection of antibodies to Mycoplasma pneumoniae in human serum. Clin Diagn Lab Immunol 7:778−780
Dominguez J, Gali N, Blaco S, Pedroso P, Prat C, Matas L, Ausona V (2001) Detection of Streptococcus pneumoniae antigen by a rapid immunochromatographic assay in urine samples. Chest 119:243−249
Gutierrez F, Masia M, Rodriguez JC, Ayelo A, Soldan B, Cebrian L, Mirete C, Royo G, Hidalgo AM (2003) Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community acquired pneumonia in Spain. Clin Infect Dis 36:286−292
Burel E, Dufour P, Gauduchon V, Jarraud S, Etienne J (2001) Evaluation of a rapid immunochromatographic assay for detection of Streptococcus pneumoniae antigen in urine samples. Eur J Clin Microbiol Infect Dis 20:840−841
Marston BJ, Plouffe JF, File TM, Hackman BA, Salstrom SJ, Lipman HB, Kolczak MS, Breiman RF, for the Community-Based Pneumonia Incidence Study Group (1997) Incidence of community-acquired pneumonia requiring hospitalization. Arch Intern Med 157:1709−1718
Gleason PP, Meehan TP, Fine JM, Galusha DH, Fine MJ (1999) Association between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 159:2562−2572
Stahl JE, Barza M, DesJardin J, Martin R, Eckman MH (1999) Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia. Arch Intern Med 159:2576−2580
Fang GD, Fine M, Orloff J, Arisumi D, Yu VL, Kapoor W, Grayston JT, Wang SP, Kohler R, Muder RR, Yee YC, Rihs JD, Vickers RM (1990) New and emerging etiologies for community-acquired pneumonia with implications for therapy. Medicine 69:307−316
Riquelme R, Torres A, El-Ebiary M, Mensa J, Estruch R, Ruiz M, Angrill J, Soler N (1997) Community-acquired pneumonia in the elderly. Am J Respir Crit Care Med 156:1908−1914
Esposito S, Bosis S, Cavagna R, Faelli N, Begliatti E, Marchisio P, Blasi F, Bianchi C, Principi N (2002) Characteristics of Streptococcus pneumoniae and atypical bacterial infections in children 2–5 years of age with community-acquired pneumonia. Clin Infect Dis 35:1345−1352
Monno R, De Vito D, Losito G, Sibilio G, Costi A, Fumarola L, D'Aprile A, Marcuccio P (2002) Chlamydia pneumoniae in community-acquired pneumonia: seven years of experience. J Infect 45:135−138
Steinhoff D, Lode H, Ruckdeschel G, Heidrich B, Rolfs A, Fehrenbach FJ, Mauch H, Hoeffken G, Wagner J (1996) Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalized patients in Berlin. Clin Infect Dis 22:958−964
Kauppinen MT, Saikku P, Kujala P, Herva E, Syrjälä H (1996) Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia. Thorax 51:185−189
Miyashita N, Fukano H, Okimoto N, Hara H, Yoshida K, Niki Y, Matsushima T (2002) Clinical presentation of community-acquired Chlamydia pneumoniae pneumonia in adults. Chest 121:1776−1781
Acknowledgements
We thank Lek d.d. Pharmaceutical Company for partial financial support of the study and Stojan Kariž, M.D., Tatjana Remec, M.D., Jani Dernič, M.D., and Mateja Logar, M.D., for their help in providing the patients.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Beović, B., Bonač, B., Keše, D. et al. Aetiology and Clinical Presentation of Mild Community-Acquired Bacterial Pneumonia. Eur J Clin Microbiol Infect Dis 22, 584–591 (2003). https://doi.org/10.1007/s10096-003-0997-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10096-003-0997-0